Triple
T10790391
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | White Oak, Maryland |
E254561
|
entity |
| Predicate | isNearFederalFacility |
P22439
|
FINISHED |
| Object |
U.S. Food and Drug Administration Office of Regulatory Science
The U.S. Food and Drug Administration Office of Regulatory Science is an FDA division that conducts scientific research and analysis to support regulatory decisions on the safety, effectiveness, and quality of food, drugs, and other products under the agency’s oversight.
|
E886013
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Food and Drug Administration Office of Regulatory Science | Statement: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Office of Regulatory Science]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Office of Regulatory Science Context triple: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Office of Regulatory Science]
-
A.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
B.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
C.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
D.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
E.
Office of Pharmaceutical Quality
The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: U.S. Food and Drug Administration Office of Regulatory Science Triple: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Office of Regulatory Science]
Generated description
The U.S. Food and Drug Administration Office of Regulatory Science is an FDA division that conducts scientific research and analysis to support regulatory decisions on the safety, effectiveness, and quality of food, drugs, and other products under the agency’s oversight.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Office of Regulatory Science Target entity description: The U.S. Food and Drug Administration Office of Regulatory Science is an FDA division that conducts scientific research and analysis to support regulatory decisions on the safety, effectiveness, and quality of food, drugs, and other products under the agency’s oversight.
-
A.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
B.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
C.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
D.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
E.
Office of Pharmaceutical Quality
The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6aa609f008190a294200aefcb7bd5 |
completed | April 8, 2026, 7:20 p.m. |
| NER | Named-entity recognition | batch_69d732f5b8248190a633dc44ae620a3a |
completed | April 9, 2026, 5:02 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69de562873b081908bea08c56b1c1e3f |
completed | April 14, 2026, 2:58 p.m. |
| NEDg | Description generation | batch_69de5eadb9448190bdf69711394e2ab7 |
completed | April 14, 2026, 3:35 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69de607917808190922df6521d7bfb07 |
completed | April 14, 2026, 3:42 p.m. |
Created at: April 8, 2026, 9:17 p.m.